Available datapackage for study 'A Randomized, Open-Label, Long-Term, Parallel-Group, Comparator-Controlled, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Exenatide Twice Daily in Subjects With Type 2 Diabetes Mellitus'

To compare the effect on glycemic control (HbA1c) of exenatide suspension administered once
weekly to that achieved by exenatide administered twice daily for 28 weeks in subjects with
type 2 diabetes mellitus.

To examine the long-term (52 weeks of treatment) safety and effect on glucose control of
exenatide suspension administered once weekly in subjects with type 2 diabetes mellitus.